Recent Security Class Actions

Caribou Biosciences Inc. Common Stock (NASDAQ: CRBU)

44 Days left to seek lead plaintiff status.

Company Name:Caribou Biosciences Inc. Common Stock
Stock Symbol:NASDAQ: CRBU
Class Period Start:07/14/2023
Class Period End (inclusive):07/16/2024
Filing Deadline:02/24/2025

According to the Complaint, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and prospects. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) they had overstated CB-010’s safety, efficacy, and durability relative to approved autologous CAR-T cell therapies in treating patients with r/r B-NHL and/or LBCL, as well as CB-010’s overall clinical results and commercial prospects; (ii) Caribou was at significant risk of having insufficient cash, liquidity, and/or other capital to fund its current business operations, including preclinical research activities associated with the allogeneic CAR-NK platform; (iii) all the foregoing was likely to have a significant negative impact on Caribou’s business and operations; and (iv) as a result, Defendants’ public statements were materially false and misleading at all relevant times.

Caribou Biosciences Inc. Common Stock (NASDAQ: CRBU) Claim Form

Name(Required)
Address
This field is for validation purposes and should be left unchanged.